Kentucky Health Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kentucky Health Wire.

Press releases published on October 13, 2026

10 hours ago

維泰瑞隆NAMPT啟動劑SIR4156的II期FORGE-LM肥胖症試驗完成約50%患者入組

Indeterminate GlobeNewswire

10 hours ago

Opus Genetics to Present at the Chardan Annual Healthcare Conference

Indeterminate GlobeNewswire

10 hours ago

Sironax Advances Enrollment in Phase 2 FORGE-LM Obesity Trial of NAMPT Activator SIR4156

Indeterminate GlobeNewswire

10 hours ago

ZoomRx Launches Marketing Asset Testing (MAT) on Sagan Agents, Bringing Continuous, Channel-Specific Asset Testing to Pharma Brand Teams

Indeterminate GlobeNewswire

10 hours ago

Aclarion to Present at the 20th Annual LD Micro Main Event

Indeterminate GlobeNewswire

10 hours ago

iBio Highlights Data from a Non-human Primate Study Supporting IBIO-610’s Potential to Preserve Muscle in Combination with GLP-1 Therapy

Indeterminate GlobeNewswire

10 hours ago

Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets

Indeterminate GlobeNewswire

10 hours ago

Triveni Bio Doses First Patient in Global Phase 2 Proof-of-Concept Study of TRIV-573 in Atopic Dermatitis and Provides I&I Pipeline Update

Indeterminate GlobeNewswire

10 hours ago

Visara Expands Ophthalmology Pipeline with Exclusive License for Investigational Nerve Growth Factor Therapy for Neurotrophic Keratitis

Indeterminate GlobeNewswire

10 hours ago

Beam Therapeutics to Present Initial Data from Phase 1/2 Trial of BEAM-301 in Glycogen Storage Disease Type Ia (GSDIa) at the ESGCT 33rd Annual Congress

Indeterminate GlobeNewswire

10 hours ago

Ever After Foods and Roslin Technologies Achieve Major Leap in Cultivated Meat Productivity

Indeterminate GlobeNewswire

10 hours ago

Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at ASBMR 2026 Annual Meeting

Indeterminate GlobeNewswire

10 hours ago

BioNTech veröffentlicht Update zur klinischen Phase-2/3-Studie des mRNA-Krebsimmuntherapiekandidaten BNT113 bei HPV16-positivem metastasiertem Kopf- und Halskrebs

Indeterminate GlobeNewswire

10 hours ago

BioNTech Provides Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy Candidate BNT113 in Metastatic HPV16-positive Head and Neck Cancer 

Indeterminate GlobeNewswire

10 hours ago

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2026

Indeterminate GlobeNewswire

11 hours ago

MADD Canada and NLC Share Sober Driving Messages with Students in Newfoundland and Labrador

Indeterminate GlobeNewswire

11 hours ago

MADD Canada et la NLC unissent leurs efforts pour sensibiliser les élèves de Terre-Neuve-et-Labrador à la conduite sobre

Indeterminate GlobeNewswire

11 hours ago

Gala Reale di Savoia to make It’s Montreal debut in support of Point d’Appui Foundation

Indeterminate GlobeNewswire

11 hours ago

Le Gala Reale Di Savoia fera ses débuts à Montréal au profit de la Fondation Point d’Appui

Indeterminate GlobeNewswire

11 hours ago

Biodesix to Present New Real-World Evidence Supporting Integration of Nodify Lung® Testing into Routine Lung Nodule Care at CHEST 2026

Indeterminate GlobeNewswire